SCHEMBL6507944

SCHEMBL6507944

C=CCOc1ccccc1Oc1cccc(C=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.49
MAOB P27338 7/20 0.49
TTR P02766 1/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
TDP1 Q9NUW8 1/20 0.42
SRC P12931 1/20 0.41
LIG1 P18858 1/20 0.40
SLC22A1 O15245 1/20 0.39
CYP1A2 P05177 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
HTR1A P08908 1/20 0.39
CYP2D6 P10635 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22215858 0.83 HPGD (0.44) LMNAMEN1ALDH1A1MAPTKMT2A
SCHEMBL29549500 0.83 MAOA (0.58) MAOAMAOBMEN1KMT2ANPC1
SCHEMBL429910 0.83 MAOA (0.58) MAOAMAOBMEN1KMT2ANPC1
SCHEMBL6504175 0.80 MAOA (0.73) MAOAMAOBTTRMEN1ALDH1A1
SCHEMBL5239038 0.80 TSHR (0.49) LMNAALDH1A1KMT2ALIG1SLC22A1
SCHEMBL2075852 0.77 TTR (0.67) MAOAMAOBTTRLMNAMEN1
3-Hydroxybenzaldehyde SCHEMBL6558945 0.77 MAOA (0.55) MAOAMAOBMEN1KMT2ANPC1
SCHEMBL3800333 0.76 HPGD (0.55) LMNAALDH1A1MAPTLIG1SLC22A1
SCHEMBL19921069 0.75 MAPK1 (0.47) LMNAMEN1ALDH1A1MAPTKMT2A
SCHEMBL3464451 0.75 FDPS (0.54) LMNAMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor CCR8, CCL11, CCR5 MAOA 3092/4885MAOB 2634/4885TTR 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.